Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
Resmed (NYSE: RMD, ASX: RMD) has scheduled its fourth quarter fiscal 2025 earnings release for Thursday, July 31, 2025, after the NYSE market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Resmed (NYSE: RMD, ASX: RMD) has scheduled its fourth quarter fiscal 2025 earnings release for Thursday, July 31, 2025, after the NYSE market close. The company will host a webcast to discuss the results at 1:30 p.m. PDT / 4:30 p.m. EDT on the same day.
The earnings webcast will be accessible through Resmed's investor relations website at investor.resmed.com. A replay will be available approximately two hours after the webcast, along with a phone replay accessible from July 31 to August 14, 2025, using the conference ID 13754703.
Details
News Market Reaction – RMD
The recorded move for RMD in the trading session of this news was -0.15%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
| • | Location: | https://investor.resmed.com | |
| • | Date: | Thursday, July 31, 2025 | |
| • | Time: | 1:30 p.m. PDT / 4:30 p.m. EDT | |
| • | International: | London, Thursday, July 31, 2025, 9:30 p.m. BST Sydney, Friday, August 1, 2025, 6:30 a.m. AEST | |
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from July 31, 2025, until August 14, 2025, at:
| • | U.S.: +1 877.660.6853 | |
| • | International: +1 201.612.7415 | |
| • | Conference ID: 13754703 | |
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For investors | For media |
| +1 858.836.5000 | +1 619.510.1281 |
| investorrelations@Resmed.com | news@Resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.